BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20584044)

  • 1. Rapid progression of a basal cell carcinoma after photodynamic therapy.
    Karen JK; Hale EK
    Dermatol Surg; 2010 Aug; 36(8):1328-31. PubMed ID: 20584044
    [No Abstract]   [Full Text] [Related]  

  • 2. Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light.
    Fink-Puches R; Wolf P; Kerl H
    Arch Dermatol; 1997 Dec; 133(12):1494-5. PubMed ID: 9420532
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of basal cell carcinoma with topical methylaminolaevulinate photodynamic therapy in an organ-transplant recipient.
    Perrett CM; Tan SK; Cerio R; Goldsmith PC; McGregor JM; Proby CM; Harwood CA
    Clin Exp Dermatol; 2006 Jan; 31(1):146-7. PubMed ID: 16309518
    [No Abstract]   [Full Text] [Related]  

  • 4. [Photodynamic therapy of nasal basal cell carcinoma].
    Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
    Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy effective for the treatment of actinic keratosis and basal cell carcinoma in bullous pemphigoid patients.
    Canavan TN; de la Feld SF; Huang C; Sami N
    Photodiagnosis Photodyn Ther; 2017 Jun; 18():257-259. PubMed ID: 28373119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
    Sotiriou E; Apalla Z; Ioannides D
    Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: photodynamic therapy with methyl aminolevulinate induces phototoxic reactions on areas of the nose adjacent to basal cell carcinomas and actinic keratoses.
    Toll A; Parera ME; VĂ©lez M; Pujol RM
    Dermatol Surg; 2008 Aug; 34(8):1145-7; discussion 1147-8. PubMed ID: 18518890
    [No Abstract]   [Full Text] [Related]  

  • 8. Keratoacanthoma aggravated after photodynamic therapy.
    Yeon JH; Jung JY; Choi JW; Kim BJ; Lee JH; Youn SW; Park KC; Huh CH
    J Dermatol; 2010 Aug; 37(8):765-6. PubMed ID: 20649727
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid.
    Cappugi P; Mavilia L; Campolmi P; Reali EF; Mori M; Rossi R
    J Chemother; 2004 Oct; 16(5):491-3. PubMed ID: 15565918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermoid cysts mimicking recurrence of superficial basal cell carcinoma following photodynamic therapy.
    Ghaffar SA; Clements SE; Lear JT
    Clin Exp Dermatol; 2007 Mar; 32(2):223-4. PubMed ID: 17137478
    [No Abstract]   [Full Text] [Related]  

  • 12. Late erythema after photodynamic therapy to the face.
    Misra A; Maybury K; Eltigani TA
    Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
    [No Abstract]   [Full Text] [Related]  

  • 13. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
    Naidenov N; Dencheva R; Tsankov N
    Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience.
    Wang XL; Wang HW; Guo MX; Xu SZ
    Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):127-33. PubMed ID: 19356643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer.
    Garcia-Zuazaga J; Cooper KD; Baron ED
    Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
    Chapas AM; Gilchrest BA
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis.
    Foley P
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S8-10; discussion S23-5. PubMed ID: 15859301
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluorescence diagnosis in actinic keratosis and squamous cell carcinoma.
    Kleinpenning MM; Wolberink EW; Smits T; Blokx WA; van De Kerkhof PC; van Erp PE; Gerritsen RM
    Photodermatol Photoimmunol Photomed; 2010 Dec; 26(6):297-302. PubMed ID: 21091787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.